Protocol Builder

Growth hormone secretagogue protocol using sermorelin for natural GH pulse stimulation. Supports anti-aging, body composition, sleep quality, and recovery without exogenous GH administration.

BPC-157 focused protocol for gastrointestinal healing, leaky gut, and inflammatory bowel support. BPC-157 (Body Protection Compound) promotes mucosal healing, angiogenesis, and anti-inflammatory pathways in the GI tract.

Topical erectile dysfunction protocol using compounded Scream Cream (Sildenafil/Arginine/Papaverine/Testosterone). Applied directly to the penile shaft for rapid local absorption. Suitable as first-line or adjunct therapy for mild-to-moderate ED.

Multi-modal protocol addressing female sexual dysfunction including hypoactive sexual desire disorder (HSDD) and arousal difficulties. Combines topical arousal cream with oxytocin for bonding and desire enhancement.

Low Dose Naltrexone protocol for autoimmune and chronic inflammatory conditions. LDN modulates the immune system by temporarily blocking opioid receptors, leading to upregulation of endorphins and enkephalins with anti-inflammatory effects.

Combination protocol using Low Dose Naltrexone for appetite regulation and craving reduction alongside GLP-1 therapy. LDN at higher doses (up to 4.5mg) can reduce food cravings and support metabolic health.

Comprehensive adrenal and neurosteroid support protocol combining DHEA and Pregnenolone for patients with adrenal insufficiency, age-related hormonal decline, or as adjunctive therapy during HRT. DHEA is a precursor to both androgens and estrogens, while Pregnenolone is the "mother hormone" precursor to all steroid hormones including cortisol, DHEA, progesterone, and aldosterone.

Protocol targeting sleep quality and stress resilience through hormonal and peptide support. Progesterone provides GABAergic calming effects, while sermorelin enhances deep sleep GH pulses.

Combined thyroid and adrenal support for patients with concurrent hypothyroidism and adrenal fatigue. Addresses the thyroid-adrenal axis connection, as adrenal dysfunction can impair thyroid hormone conversion.

Classic testosterone replacement therapy for hypogonadal males. Includes testosterone cypionate as the primary androgen, anastrozole for estrogen management, and HCG to maintain testicular function and fertility.

Low-dose GLP-1 weight management protocol combining Semaglutide with Ondansetron ODT (orally disintegrating tablet) for nausea management. This protocol is designed for GLP-1 naive patients or those sensitive to GI side effects. Ondansetron (a 5-HT3 antagonist) is co-prescribed to mitigate the common nausea associated with GLP-1 receptor agonist initiation and dose escalation.

Topical combination cream for female sexual dysfunction containing Sildenafil, L-Arginine, Papaverine, and Testosterone. Applied directly to genital tissue to enhance blood flow, sensitivity, and arousal. Sildenafil and Papaverine are vasodilators that increase local blood flow, L-Arginine is a nitric oxide precursor, and Testosterone supports libido and tissue sensitivity.

First-line erectile dysfunction protocol using oral PDE5 inhibitors. Tadalafil provides a longer duration of action (up to 36 hours) for on-demand or daily use, with sildenafil as an alternative for faster onset.

Aggressive multi-modal weight loss protocol combining injectable GLP-1 receptor agonist (Semaglutide) with lipotropic injections, low-dose naltrexone for craving reduction, and B12 for energy support. For patients requiring maximum intervention.

Injectable lipotropic protocol combining MIC (Methionine, Inositol, Choline) with B12 for enhanced fat metabolism, energy production, and liver support. Popular adjunct to diet and exercise programs.

Post-cycle therapy protocol for patients transitioning off exogenous testosterone or anabolic therapy. Designed to restore endogenous HPG axis function, prevent estrogen rebound, and maintain gains during recovery.

Full-spectrum male optimization protocol combining TRT, estrogen management, growth hormone secretagogue, and metabolic support. For patients seeking comprehensive hormonal, body composition, and performance optimization.

Early intervention protocol for perimenopausal women experiencing irregular cycles, mood changes, and early vasomotor symptoms. Focuses on progesterone support and gentle estrogen supplementation before full HRT is needed.

Fertility and hormonal support protocol using HCG (Human Chorionic Gonadotropin) and Gonadorelin to stimulate endogenous testosterone production, support spermatogenesis, and maintain fertility during or after TRT. HCG mimics LH to stimulate Leydig cells, while Gonadorelin stimulates pulsatile GnRH release to maintain the HPG axis.

Testosterone replacement combined with low-dose nandrolone decanoate for patients with concurrent joint pain, osteoarthritis, or connective tissue issues. Nandrolone provides anabolic joint-protective effects and collagen synthesis stimulation.

Advanced peptide combination for accelerated tissue repair, injury recovery, and anti-inflammatory support. Combines BPC-157 for tissue healing with TB-500 (Thymosin Beta-4) for cellular migration and wound repair.

Intravenous or injectable glutathione protocol for detoxification, immune support, and skin health. Glutathione is the body's master antioxidant, critical for Phase II liver detoxification and cellular protection.

Testosterone replacement combined with PDE5 inhibitor support for patients with concurrent erectile dysfunction. Addresses both hormonal and vascular components of sexual health.

Comprehensive hormone replacement for perimenopausal and postmenopausal women. Combines bioidentical estrogen and progesterone to manage vasomotor symptoms, bone health, and quality of life.

Female hormone replacement with added low-dose testosterone and oxytocin for patients with hypoactive sexual desire disorder (HSDD) alongside menopausal symptoms.

GLP-1 receptor agonist-based weight management protocol. Semaglutide provides appetite suppression and metabolic benefits, supported by B12 for energy and optional naltrexone for craving reduction.

Dual GIP/GLP-1 receptor agonist protocol using tirzepatide for enhanced weight loss. Tirzepatide offers superior weight reduction compared to single-agonist approaches.

Comprehensive thyroid support protocol combining T4 and T3 for patients with hypothyroidism not fully optimized on T4 monotherapy. Addresses both conversion issues and direct T3 supplementation.

Peptide-based protocol for tissue repair, recovery, and anti-inflammatory support. BPC-157 promotes gut and tissue healing while sermorelin supports growth hormone release for recovery.

Evidence-based longevity protocol combining rapamycin (mTOR inhibition), NAD+ precursors, and antioxidant support for cellular health and healthy aging.

Multi-modal approach to androgenetic alopecia combining DHT reduction, topical growth stimulation, and nutritional support for hair follicle health.

Protocol designed to optimize male fertility while maintaining or restoring testosterone levels. Focuses on gonadotropin stimulation and avoiding testosterone suppression of spermatogenesis.

Comprehensive adrenal support protocol for patients with adrenal fatigue or HPA axis dysfunction. Combines DHEA, pregnenolone, and B-vitamin support for cortisol rhythm restoration.

BPC-157 is a pentadecapeptide with a wide range of healing and regenerative properties. This protocol is designed for providers to use BPC-157 to accelerate the healing of various tissues, including muscle, tendon, ligament, and bone, as well as to improve gut health and address inflammatory conditions.

This protocol combines four powerful peptides—BPC-157, GHK-Cu, KPV, and TB-500—to provide a multi-faceted approach to healing and regeneration. It is designed for comprehensive tissue repair, potent anti-inflammatory effects, and enhanced skin and connective tissue health. The synergistic action of these peptides makes it a robust option for patients with complex injuries or those seeking advanced recovery and rejuvenation.

This advanced protocol combines the synergistic effects of BPC-157, TB-500, and GHK-Cu to provide comprehensive support for tissue regeneration. BPC-157 and TB-500 work together to accelerate the healing of muscles, tendons, and ligaments, while GHK-Cu promotes collagen synthesis and skin repair. This powerful combination is designed for providers seeking to offer patients a multi-faceted approach to recovery and anti-aging.

This protocol combines the synergistic effects of BPC-157, KPV, and TB500 to offer a powerful solution for tissue repair, gut healing, and inflammation reduction. BPC-157 and TB500 work together to accelerate the healing of soft tissues, while KPV provides potent anti-inflammatory action, making this combination ideal for complex injuries and chronic inflammatory conditions.

This protocol combines BPC-157 and TB-500 to create a powerful synergistic effect for healing. BPC-157 offers potent localized tissue repair and anti-inflammatory benefits, while TB-500 promotes systemic healing, cell migration, and angiogenesis. This dual-action approach is prescribed for comprehensive and accelerated recovery from various musculoskeletal injuries.

This protocol combines CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue and ghrelin receptor agonist. Together, they synergistically increase the pulsatile release of growth hormone from the pituitary gland. This dual-action approach provides a sustained elevation in GH and IGF-1 levels, making it a powerful tool for providers seeking to optimize body composition, enhance recovery, and address age-related growth hormone decline in patients.

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that plays a crucial role in the regulation of deep, restorative sleep. This protocol is designed for providers to use with patients experiencing insomnia, disrupted sleep architecture, or poor sleep quality, aiming to normalize sleep cycles and improve overall sleep efficiency without the side effects of traditional hypnotics.

This protocol combines three peptides—DSIP, BPC-157, and CJC-1295—to create a powerful synergistic blend for sleep, tissue repair, and growth hormone optimization. DSIP (Delta Sleep-Inducing Peptide) helps regulate deep sleep cycles, BPC-157 accelerates tissue healing and reduces inflammation, and CJC-1295 stimulates the body's natural production of growth hormone. It is prescribed for patients seeking comprehensive recovery, anti-aging benefits, and improved sleep quality.

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that functions as a telomerase activator, playing a crucial role in regulating the cell cycle and combating age-related decline. By stimulating telomerase, Epithalon helps to elongate telomeres, the protective caps at the ends of chromosomes, thereby protecting DNA from damage and cellular senescence. This protocol is designed for providers seeking to offer patients an evidence-based approach to promoting longevity, improving cellular health, and mitigating the physiological effects of aging.

GHK-Cu is a naturally occurring copper peptide with extensive regenerative and protective properties. This protocol is designed to leverage GHK-Cu's ability to upregulate collagen and elastin production, accelerate wound healing, and reduce inflammation, making it a powerful treatment for skin rejuvenation and hair loss.

This protocol leverages the synergistic effects of GHK-Cu and Epithalon for comprehensive anti-aging and skin rejuvenation. GHK-Cu, a copper peptide, stimulates collagen and elastin production, improves skin firmness, and accelerates wound healing for a revitalized appearance. Epithalon works at the cellular level by activating telomerase to protect DNA and regulate circadian rhythms, combating the root causes of aging.

This protocol uses Gonadorelin, a synthetic analog of gonadotropin-releasing hormone (GnRH), to stimulate the pituitary gland's production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is prescribed for female infertility caused by hypothalamic amenorrhea to induce ovulation. It is also used in males on testosterone replacement therapy (TRT) to prevent testicular atrophy and maintain endogenous testosterone production.

This protocol utilizes IGF-1 LR3, a long-acting analog of insulin-like growth factor-1, to stimulate muscle growth (hyperplasia and hypertrophy) and accelerate recovery. It is prescribed for patients seeking enhanced athletic performance, improved body composition, and mitigation of age-related muscle loss.

This protocol utilizes Kisspeptin, a potent upstream regulator of the reproductive axis, to stimulate the release of Gonadotropin-Releasing Hormone (GnRH). It is prescribed for patients with suspected hypothalamic-pituitary-gonadal (HPG) axis dysfunction to diagnose and treat conditions like hypogonadotropic hypogonadism and functional hypothalamic amenorrhea.

MOTS-c is a mitochondrial-derived peptide that plays a crucial role in regulating metabolic homeostasis and cellular energy. This protocol is intended for patients looking to improve insulin sensitivity, optimize metabolic function, and increase overall vitality and exercise performance, particularly in the context of age-related metabolic decline.

This protocol is designed to counteract the age-related decline in Nicotinamide Adenine Dinucleotide (NAD+), a critical coenzyme for cellular energy metabolism and DNA repair. By restoring NAD+ levels, this therapy aims to enhance mitochondrial function, boost cellular energy production, and activate sirtuins, which are key proteins involved in longevity and cellular health. It is prescribed for patients seeking to improve vitality, cognitive function, and overall wellness as part of a comprehensive anti-aging strategy.

This advanced protocol combines three synergistic peptides—Pinealon, PE-22-28, and Selank—to offer comprehensive cognitive enhancement, neuroprotection, and anxiolytic benefits. It is designed for patients seeking to improve memory, focus, and mental clarity while simultaneously reducing anxiety and improving mood. The combination of these peptides provides a multi-faceted approach to brain health and cognitive performance.

PT-141 (Bremelanotide) is a synthetic peptide and melanocortin receptor agonist used to treat sexual dysfunction in both men and women. It is particularly effective for hypoactive sexual desire disorder (HSDD) by acting on the central nervous system to increase sexual desire and arousal. This protocol is designed for patients seeking to improve libido and overall sexual satisfaction.

This protocol combines the nootropic effects of Semax with the anxiolytic properties of Selank to offer a comprehensive approach to cognitive enhancement and mood regulation. Semax is known to improve memory, focus, and learning, while Selank helps to reduce anxiety and stress without causing sedation. The synergistic action of this combination makes it a valuable tool for providers treating patients with cognitive decline, brain fog, or anxiety-related conditions.

This protocol uses Sermorelin, a growth hormone-releasing hormone (GHRH) analog, to stimulate the patient's own pituitary gland to produce and release growth hormone. It offers a more natural and pulsatile approach to optimizing GH levels compared to direct administration of human growth hormone (HGH), which can suppress natural production. Providers would prescribe this to address age-related growth hormone decline and its associated symptoms.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue that stimulates the pituitary gland to secrete growth hormone. This protocol is designed to reduce visceral adipose tissue (VAT) in patients with lipodystrophy, particularly in the context of HIV, but it is also used off-label for general visceral fat reduction. By increasing endogenous growth hormone and IGF-1 levels, it promotes lipolysis and can improve body composition and metabolic parameters.

This protocol combines Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone (GH) secretagogue. Together, they synergistically enhance the body's natural production and release of GH to support fat loss, particularly visceral adipose tissue, and promote lean muscle mass. This dual-action approach provides a more potent and physiologic stimulation of the GH axis compared to single-agent therapies.

Thymosin Alpha-1 is a synthetic peptide that is a potent modulator of the immune system. This protocol is designed to enhance immune surveillance and response, particularly in immunocompromised individuals or those with chronic infections, by stimulating T-cell production and maturation. It is used to restore immune function and help the body defend against various pathogens and malignancies.

5-Amino-1MQ is a novel small molecule that inhibits the enzyme Nicotinamide N-methyltransferase (NNMT), leading to increased NAD+ levels and enhanced cellular metabolism. Available as both injectable and oral capsule formulations for flexible dosing.

This advanced protocol combines SLU-PP-332, a novel exercise mimetic, with BAM15, a potent mitochondrial uncoupler. SLU-PP-332 activates metabolic pathways normally stimulated by exercise, while BAM15 enhances cellular energy expenditure. This synergistic action promotes significant fat loss, improves insulin sensitivity, and enhances overall metabolic function, making it a powerful therapeutic for metabolic syndrome and obesity.

SLU-PP 332 is a novel, orally active ERR agonist that functions as an exercise mimetic. This protocol is designed for providers looking to offer a cutting-edge therapy for patients struggling with metabolic syndrome, obesity, or who wish to enhance their response to exercise. By activating the ERRα, β, and γ receptors, SLU-PP 332 stimulates metabolic pathways typically activated by aerobic exercise, leading to increased fatty acid oxidation and improved energy expenditure.

This protocol leverages Glutathione, the body's master antioxidant, to protect cells from oxidative damage, support natural detoxification processes, and enhance immune function. It is prescribed for patients seeking to improve their overall wellness, skin health, and resilience against environmental stressors.

The Lipo-B Metabolic Support Protocol is a series of lipotropic injections containing a blend of Methionine, Inositol, Choline (MIC), and Vitamin B12. These ingredients work synergistically to enhance fat metabolism, prevent the accumulation of fats in the liver, and increase energy levels. This protocol is designed for providers to complement a patient's existing weight management plan, including diet and exercise.

A protocol for the use of compounded Doxycycline suspension, a tetracycline antibiotic, for treating a variety of bacterial infections in patients who require liquid formulations or customized dosing.

A broad-spectrum tetracycline antibiotic protocol for treating bacterial infections, acne, and certain tick-borne illnesses.

A clinical protocol for the use of compounded ivermectin suspension for precise liquid dosing and weight-based antiparasitic treatment.

A clinical protocol for the use of oral Ivermectin, a broad-spectrum antiparasitic agent, for the treatment of various parasitic worm infections. This protocol outlines dosing, monitoring, and safety guidelines for the effective and safe use of Ivermectin.

A protocol for the use of topical Ivermectin cream to treat inflammatory lesions of rosacea and certain parasitic skin infections by leveraging its anti-inflammatory and anti-parasitic properties.

A compounded topical formulation combining Finasteride and Minoxidil to provide a dual-action approach to treating androgenetic alopecia (male pattern hair loss). This protocol leverages the synergistic effects of a 5-alpha reductase inhibitor and a potassium channel opener to reduce hair loss and promote new growth.

Oral Dutasteride capsules that block both Type I and Type II 5-alpha reductase for comprehensive DHT suppression, promoting hair regrowth and preventing further hair loss in men with androgenetic alopecia.

Oral Finasteride capsules that block DHT conversion to slow hair loss and promote regrowth.

A protocol for the use of topical Finasteride solution to treat androgenetic alopecia (male pattern hair loss) by blocking dihydrotestosterone (DHT) at the scalp, minimizing systemic absorption and side effects.

Low-dose oral Minoxidil capsules for systemic hair growth stimulation. This protocol is designed for patients with androgenetic alopecia and other forms of hair loss who have not responded to or are intolerant of topical therapies.

A topical protocol using Minoxidil to stimulate hair follicles, promote hair regrowth, and slow down the progression of androgenetic alopecia (pattern hair loss) in both men and women.

A triple-combination topical medication for male androgenetic alopecia, leveraging the synergistic effects of finasteride, minoxidil, and tretinoin to reduce hair loss and promote regrowth.

A clinical protocol for the use of Anastrozole, an aromatase inhibitor, to manage estrogen levels in men undergoing Testosterone Replacement Therapy (TRT). This protocol aims to prevent adverse effects of excess estrogen conversion, such as gynecomastia and mood swings.

A protocol for using Enclomiphene, a selective estrogen receptor modulator (SERM), to stimulate the body's own testosterone production while preserving fertility in men with secondary hypogonadism.

Topical testosterone cream for treating male hypogonadism. It provides a steady absorption of testosterone through the skin, offering a needle-free alternative to injections for hormone replacement therapy.

This protocol outlines the use of a compounded testosterone hypo spray for the treatment of male hypogonadism. The goal is to restore testosterone levels to a normal physiological range, thereby improving symptoms of testosterone deficiency such as low libido, fatigue, and reduced muscle mass.

A clinical protocol for testosterone replacement therapy (TRT) in men using sublingual testosterone troches. This protocol outlines the use of compounded testosterone troches that dissolve under the tongue for rapid absorption to treat symptoms of hypogonadism.

A compounded topical cream combining Nandrolone, an anabolic steroid, with Testosterone to provide joint support and optimize hormone levels in men. This protocol is designed for men experiencing symptoms of andropause and seeking enhanced recovery and joint health.

This protocol uses Clomiphene Citrate, a selective estrogen receptor modulator (SERM), to increase testosterone and sperm production in men. It is designed for men experiencing infertility due to low sperm count or poor sperm motility.

A protocol for using Tamoxifen, a selective estrogen receptor modulator (SERM), for post-cycle therapy (PCT) or as an estrogen blocker to restore natural hormone production after a cycle of anabolic steroids.

A compounded formulation of Caffeine and Sildenafil designed to enhance energy levels and improve erectile function, providing a dual-action approach to sexual performance.

A clinical protocol for the on-demand treatment of erectile dysfunction (ED) using Sildenafil, a phosphodiesterase-5 (PDE5) inhibitor that enhances erectile response to sexual stimulation.

A compounded combination of Sildenafil and Tadalafil for enhanced erectile response. This protocol utilizes two phosphodiesterase-5 (PDE5) inhibitors with different pharmacokinetic profiles to provide both rapid onset and extended duration of action for the treatment of erectile dysfunction.

Low-dose Tadalafil taken daily for continuous erectile support, providing a steady state of the medication in the body for improved erectile function.

This protocol outlines the use of higher-dose Tadalafil taken as needed for the on-demand treatment of erectile dysfunction (ED). It is intended for patients who require a more potent effect or have not responded adequately to lower doses.

A combination of two peptides, CJC-1295 and Ipamorelin, delivered via oral rapidly disintegrating tablets to stimulate the body's own production of growth hormone. This protocol is designed for individuals seeking the benefits of growth hormone optimization without the need for injections.

A protocol for utilizing Sermorelin, a growth hormone-releasing hormone (GHRH) analog, in an oral troche form to stimulate the body's own production of growth hormone. This needle-free approach offers a convenient way to address age-related growth hormone decline.

A clinical protocol for the oral administration of BPC-157, a synthetic peptide based on a naturally occurring protein in the stomach, to support systemic recovery and gut health. This protocol outlines the use of BPC-157 for its potential to accelerate tissue healing, reduce inflammation, and address gastrointestinal issues.

High-dose Oxandrolone protocol for significant anabolic support and lean muscle building under medical supervision. Oxandrolone (Anavar) is a Schedule III controlled substance requiring careful monitoring of liver function and lipid profiles.

A protocol for low-dose Oxandrolone (Anavar) to support lean muscle preservation, improve body composition, and provide mild anabolic effects with a focus on safety and minimizing androgenic side effects.

A protocol for the use of Stanozolol (Winstrol) for experienced users seeking lean muscle hardening, increased strength, and enhanced vascularity without significant water retention. This protocol is designed for advanced users familiar with anabolic-androgenic steroids (AAS).

A clinical protocol for the use of topical tretinoin to treat photoaging, reduce fine lines and wrinkles, and improve overall skin texture and appearance.

A compounded nipple cream for breastfeeding mothers to treat and prevent nipple pain, cracking, and infection by combining an antibiotic, an anti-inflammatory, and an antifungal agent.

Ondansetron is a selective 5-HT3 receptor antagonist used for the prevention of nausea and vomiting associated with cancer chemotherapy, radiation therapy, and surgery. It is also used off-label for nausea and vomiting from other causes, including as an adjunct with GLP-1 medications.

A compounded bioidentical thyroid hormone replacement protocol combining T3 and T4 to optimize thyroid function and alleviate symptoms of hypothyroidism.

A high-dose Semaglutide protocol for patients who have demonstrated tolerance to lower doses and require continued, significant weight loss. This protocol includes Methylcobalamin (B12) to support metabolic functions and energy levels during treatment.

A beginner-focused protocol for initiating weight loss using low-dose compounded Semaglutide combined with Methylcobalamin (B12). This protocol is designed for a safe and gradual start to GLP-1 therapy.

A clinical protocol for utilizing compounded sublingual semaglutide oral drops for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.

A high-dose semaglutide protocol for significant weight loss, combined with ondansetron ODT to effectively manage potential nausea associated with GLP-1 therapy.

A high-dose, compounded Tirzepatide protocol for individuals seeking significant weight loss. This protocol is designed for patients who have experience with GLP-1/GIP agonists and require a more aggressive approach to achieve their weight management goals.

This protocol is designed for the initiation of Tirzepatide, a dual GIP and GLP-1 receptor agonist, for chronic weight management in adults. It involves a low starting dose with gradual titration to improve tolerability and achieve sustainable weight loss.

A clinical protocol for weight management using Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is formulated as sublingual drops for needle-free administration, promoting weight loss by increasing insulin sensitivity, slowing gastric emptying, and reducing appetite.

A high-dose Tirzepatide protocol for significant weight loss, combined with Ondansetron ODT to effectively manage potential nausea, a common side effect of GLP-2 agonists.

A low-dose Tirzepatide protocol for weight management, bundled with Ondansetron ODT to proactively manage nausea during the initial titration phase, improving tolerability and adherence.

A protocol for utilizing metformin for metabolic support, improving insulin sensitivity, and as an adjunct for weight management, particularly in individuals with insulin resistance or pre-diabetes.

A clinical protocol for the short-term management of exogenous obesity using phentermine, a sympathomimetic amine appetite suppressant. This protocol is intended for patients with an initial BMI of ≥30 kg/m² or ≥27 kg/m² with other risk factors.

A starter protocol for Low-Dose Naltrexone (LDN) designed for immune modulation. This protocol begins at sub-therapeutic doses and gradually titrates up to a target dose, allowing for gentle introduction and monitoring of effects.

A therapeutic protocol utilizing low-dose naltrexone (LDN) for established patients to modulate the immune system and reduce inflammation associated with various chronic conditions.

A protocol for administering Nicotinamide Adenine Dinucleotide (NAD+) to support cellular energy production, promote anti-aging pathways, and enhance neuroprotection.

A protocol for the intranasal administration of Nicotinamide Adenine Dinucleotide (NAD+) to support cellular energy, cognitive function, and healthy aging. This non-injectable route offers convenient and rapid absorption.

A protocol designed to leverage the cellular benefits of topical Nicotinamide Adenine Dinucleotide (NAD+) for localized rejuvenation and improved skin health. This protocol focuses on enhancing skin appearance, texture, and resilience through the topical application of NAD+.

A protocol for administering injectable glutathione, a master antioxidant, to support detoxification, immune function, and cellular health.

A protocol for oral glutathione supplementation to support systemic antioxidant status, detoxification, and overall cellular health.

A topical protocol designed to leverage the antioxidant and depigmenting properties of glutathione for enhanced skin brightness, texture, and overall health.

A low-dose Methylene Blue protocol designed for mitochondrial support, cognitive enhancement, and neuroprotection. This starter protocol is for individuals new to Methylene Blue and aims to improve cellular energy production and protect the brain from oxidative stress.

A protocol for established patients utilizing therapeutic-dose methylene blue to optimize mitochondrial function, enhance cognitive performance, and support overall neurological health. This protocol is designed for proactive individuals seeking to improve memory, focus, and mental clarity through targeted metabolic and antioxidant support.

A protocol for liver protection and detoxification support using Milk Thistle (Silymarin), a natural compound with antioxidant and anti-inflammatory properties that supports liver health and function.

High-dose Melatonin for deep sleep support, circadian rhythm optimization, and antioxidant benefits.

A clinical protocol for the use of low-dose melatonin to support sleep onset and regulate circadian rhythms. This protocol is intended for individuals experiencing difficulty falling asleep.

A synergistic blend of Vitamin D3 and K2 to support bone health, optimize calcium metabolism, and bolster the immune system. This protocol is designed for individuals seeking to improve their overall wellness and address potential nutrient deficiencies.

A lipotropic formulation designed to support fat metabolism, enhance energy levels, and promote liver detoxification through a combination of methionine, inositol, choline, and vitamin B12.

A compounded triple-hormone therapy combining BiEst (estradiol/estriol), progesterone, and testosterone in a topical cream. This formulation is designed for comprehensive management of menopausal symptoms and hormonal imbalances in women, offering a balanced approach to hormone replacement.

A compounded dual-hormone cream combining BiEst (estradiol and estriol) and progesterone for comprehensive management of menopausal symptoms and hormone replacement therapy in women.

This protocol outlines the use of oral estradiol for systemic estrogen replacement in menopausal and perimenopausal women to manage vasomotor and vulvovaginal symptoms.

A protocol for the use of transdermal estradiol patches to manage vasomotor symptoms associated with menopause and prevent postmenopausal osteoporosis.

This protocol outlines the use of topical estradiol for the treatment of vasomotor and vulvovaginal symptoms associated with menopause. It provides a framework for safe and effective hormone replacement therapy using transdermal estrogen.

Oral micronized progesterone for hormone balance, endometrial protection, and sleep support.

This protocol outlines the use of compounded progesterone vaginal suppositories for localized hormone delivery. It is primarily used for endometrial support in the context of hormone replacement therapy (HRT) or assisted reproductive technology (ART) to ensure adequate endometrial development and maintenance.

A compounded vaginal cream combining Estradiol and DHEA for the treatment of vaginal atrophy and genitourinary syndrome of menopause (GSM).

Estradiol vaginal cream is a local estrogen therapy used to treat atrophic vaginitis (vaginal atrophy) due to menopause. It helps to relieve symptoms such as vaginal dryness, itching, and burning, as well as pain during sexual intercourse.

Combination therapy pairing Oxytocin with either Sildenafil or PT-141 for comprehensive female sexual health support, addressing both physiological and psychological aspects of sexual arousal and desire.

This protocol outlines the use of Bremelanotide (PT-141), a melanocortin receptor agonist, for the treatment of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. PT-141 works by activating key pathways in the brain involved in sexual response.

A protocol for enhancing intimacy, bonding, and sexual satisfaction through the use of oxytocin, the "love hormone". This protocol is designed for women seeking to improve their connection with their partner and enhance their overall sexual experience.